USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates

Oct. 25, 2022 5:53 PM ETUSANA Health Sciences, Inc. (USNA)By: Jonathan Block, SA News Editor

Quarterly results


  • USANA Health Sciences (NYSE:USNA) is down 17% in after-hours trading after revising its fiscal 2022 net sales and diluted EPS outlook to below Street consensus.
  • The nutritional and personal care products maker now expects net sales of $955M to $975M ($1.03B consensus) and diluted

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.